Genmab — Januar 2024
-
New Phase 3 trial, EPCORE FL-2, Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma https://clinicaltrials.gov/study/NCT06191744
-
Nice one EL - but what the #%&& does study start “ 2026-03-09” mean? Study duration 120 weeks is a bit more digestable
-
Ja, alene første sætning (ref Finans artiklen, 08:58): "Det danske biotekselskab Genmab specialiseret i moderne kræftbehandlinger kan være på vej ind i en ny fase med lav vækst efter år med utrolig vækst." Det er helt i hegnet i skoven at kalde en potentiel mindre vækst 7 år ude i fremtiden for "kan være på vej ind i". Enten forstår studentermedhjælperen ikke dansk. Eller osse manipulerer han bevidst. Jeg håber ikke Finans bifalder nogen af delene?!?
-
Driving Disruption: Brad Bailey Of Genmab On The Innovative Approaches They Are Taking To Disrupt Their Industries https://medium.com/authority-magazine/driving-disruption-brad-bailey-of-genmab-on-the-innovative-approaches-they-are-taking-to-disrupt-08414da9c0b1
-
“Blandt potentielle købere i 2024, ser vi Johnson & Johnson og Novo som mest tilbøjelige til at deltage i megahandler til en værdi af over 20 mia. dollar (136 mia. kr.), baseret på virksomhedernes opkøbsevne,” skriver Bank of America i en analyse af udviklingen på M&A for 2024. https://borsen.dk/nyheder/virksomheder/storbank-novo-nordisk-klar-til-megaopkob?b_source=borsen&b_medium=row_0&b_campaign=news_4
-
Novartis interested in Interleukin-15 https://www.b3cnewswire.com/202401082504/calypso-enters-into-agreement-to-be-acquired-by-novartis.html -we can't be too far away from getting data on PRV-015 i would imagine, maybe towards the summer
-
JNJ buying another ADC biotech , Ambrx https://finance.yahoo.com/news/johnson-johnson-acquire-ambrx-advancing-123000192.html
-
Merck buying a small Tcell engager biotech, Harpoon Therapeutics https://finance.yahoo.com/news/merck-acquire-harpoon-therapeutics-further-123000116.html
-
Johnson & Johnson i milliardopkøb på kræftområdet https://www.proinvestor.com/investornyt/1100387/johnson-johnson-i-milliardopkob-pa-kraeftomradet
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind